Marshall Edwards Raises $2M In Private Placement

San Diego-based Marshall Edwards, a publicly held firm focused on development of oncology drugs, said Thursday that it has raised $2M in a private placement. The funding came from its majority shareholder, Novogen Limited. Marshall Edwards said the new funding will go towards continued development of its lead oncology drug candidates. The firm is working on small molecule drugs which inhibit tumor cell metabolism.